JSPR - CLLS BBIG and GNLN among pre market gainers
NeuroBo Pharmaceuticals (NASDAQ:NRBO) +23% announces positive recommendation from independent data safety monitoring committee of phase 2/3 clinical trial of ANA001 in hospitalized patients with moderate to severe COVID-19 Jasper Therapeutics (NASDAQ:JSPR) +22% after bullish call from Oppenheimer Sentage Holdings (NASDAQ:SNTG) +17%. SMART Global Holdings (NASDAQ:SGH) +13% on FQ4 earnings. Koss Corporation (NASDAQ:KOSS) +13% after Apple rebuffed in patent challenges RLX Technology (NYSE:RLX) +12%. Revance Therapeutics (NASDAQ:RVNC) +12% continues to anticipate FDA approval of DaxibotulinumtoxinA for iIjection in 2021 Cellectis (NASDAQ:CLLS) +9%. Sphere 3D (NASDAQ:ANY) +8% on hosting deal Vistra (NYSE:VST) +8% to undertake $2B share buyback program; prices preferred stock offering Progenity (NASDAQ:PROG) +8% gets several USPTO patents for co's ingestible technologies Plug Power (NASDAQ:PLUG) +7% pops on Airbus green hydrogen partnership Xiaobai Maimai (NASDAQ:HX) +10%. DatChat (NASDAQ:DATS) +8%. PhaseBio Pharmaceuticals (NASDAQ:PHAS) +7%. Redwire (NYSE:RDW) +6%. Vinco Ventures (NASDAQ:BBIG) +6%. Greenlane Holdings (NASDAQ:GNLN) +6%. Clarus Therapeutics Holdings (NASDAQ:CRXT) +6%. BiomX (NYSE:PHGE) +5% after atopic dermatitis candidate, BX005 deal with Maruho
For further details see:
CLLS, BBIG and GNLN among pre market gainers